EBS
Emergent BioSolutions Inc. is a global life sciences firm specializing in the development, manufacturing, and commercialization of medical countermeasures for public health threats. The company focuses on vaccines and therapeutics for infectious diseases, opioid overdose, and chemical or biological threats. It collaborates with governments and healthcare organizations to enhance preparedness and response capabilities, ensuring rapid access to critical treatments during emergencies. Known for its expertise in biodefense, the company plays a vital role in safeguarding public health through innovation and strategic partnerships. Its portfolio includes FDA-approved products aimed at addressing urgent medical needs.
| Name | CIK | Position |
|---|---|---|
| loading... | ||